Diuretic Therapy

Mechanism of Action and Effects

• Furosemide increases sodium excretion up to 20-25% of the filtered sodium load and enhances free water clearance, which can affect serum sodium concentration, according to the American College of Cardiology 1
• The American College of Cardiology recommends monitoring serum sodium and potassium levels regularly during furosemide therapy, with target serum potassium concentrations in the 4.0-5.0 mmol/L range 1
• Furosemide works by inhibiting sodium and chloride reabsorption in the loop of Henle, increasing sodium excretion and enhances free water clearance, according to the American College of Cardiology 1

Hyponatremia and Hypokalemia

• Furosemide can lead to hyponatremia, particularly in high-risk patients such as those with heart failure, and hypokalemia, which increases risks when using other medications, according to the American College of Cardiology 1
• Two types of hyponatremia may develop: hypovolemic hyponatremia, from excessive diuresis causing negative sodium balance, and hypervolemic hyponatremia, more common in cirrhosis, due to non-osmotic vasopressin release and impaired free water clearance 2
• Patients with cirrhosis are at increased risk for developing hyponatremia with furosemide, particularly hypervolemic hyponatremia, which occurs due to non-osmotic hypersecretion of vasopressin and enhanced proximal nephron sodium reabsorption 3, 2, 4

Management and Precautions

• The American College of Cardiology recommends temporarily discontinuing furosemide if serum sodium falls below 125 mmol/L, or if significant hypokalemia or hyperkalemia develops 1, 2
• In patients with heart failure taking ACE inhibitors or aldosterone antagonists, routine potassium supplementation may be unnecessary and potentially harmful, according to the American College of Cardiology 1
• High-risk patients, including those with cirrhosis, heart failure, or the elderly, require special attention to sodium levels when receiving diuretic therapy 3, 2
• Monitor all patients receiving furosemide for signs of hyponatremia, which can include weakness, lethargy, drowsiness, restlessness, and confusion, as per the American College of Cardiology 1
• The following table summarizes the key points for monitoring and managing electrolyte abnormalities in patients receiving furosemide:

Treatment Guidelines

• The American College of Cardiology recommends furosemide as a cornerstone of therapy for fluid overload in heart failure and other conditions, despite the risks of electrolyte abnormalities, which can be mitigated through careful monitoring and dose adjustment 1
• Fluid restriction is not necessary unless serum sodium is less than 120-125 mmol/L, as per hepatology guidelines 3, 4
• Consider temporary withdrawal of furosemide if significant hyponatremia develops, as per Gut guidelines 2